Source comparison
Mechanism of Action — Immune vs Neuromodulatory Pathways
Pe-22-28 operates through thymic peptide signaling. Specifically, it binds to receptors on thymic epithelial cells and immature T-cells to promote CD4+ differentiation and Treg cell expansion. Research published in Immunology Letters (2019) demonstrated that P
This comparison does not assign a generated winner or score.
- Pe-22-28 operates through thymic peptide signaling. Specifically, it binds to receptors on thymic epithelial cells and immature T-cells to promote CD4+ differentiation and Treg cell expansion. Research published in Immunology Letters (2019) demonstrated that Pe-22-28 administration in aged murine models restored thymic output of naive T-cells by 34% and increased Foxp3+ Treg populations by 27% compared to controls. The peptide also modulates cytokine expression: it upregulates IL-2 and IL-7 (essential for T-cell survival and proliferation) while suppressing pro-inflammatory IL-6 and TNF-α in activated macrophages. The immunological endpoint is restoration of self-tolerance and reduction of inflammatory signaling. Which is why research applications focus on autoimmune disease models, transplant rejection studies, and age-related immune decline.
- Selank Amidate's mechanism centers on neurotransmitter modulation and neurotrophic signaling. It acts as a selective enkephalinase inhibitor, preventing the breakdown of endogenous enkephalins (endogenous opioid peptides that regulate stress response and emotional processing). By maintaining elevated enkephalin levels, Selank Amidate enhances GABA-ergic transmission in the amygdala and hippocampus, producing anxiolytic effects without sedation or motor impairment. A 2021 study in Neuroscience and Behavioral Physiology found that Selank Amidate increased hippocampal BDNF (brain-derived neurotrophic factor) expression by 41% in chronic stress models, suggesting neuroprotective effects beyond acute anxiety reduction. The peptide does not interact with thymic tissue or immune cell receptors. Its therapeutic window is entirely CNS-focused.